CTOs on the Move

Titan Health Corporation

www.titanhealth.com

 
Titan Health Corporation is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Horizon Treatment Services

Horizon Services provides a safe and effective place for individuals to receive addiction treatment and begin their journey toward sustainable, fulfilling recovery. Our Mission is to cultivate or restore a sense of hope, self-awareness and community to people impacted by substance use and mental health challenges by providing effective trauma informed prevention, treatment, and recovery services.

Medical University of South Carolina Health

The Medical University of South Carolina (MUSC) is a public institution of higher learning the purpose of which is to preserve and optimize human life in South Carolina and beyond. The university provides an interprofessional environment for learning and discovery through education of health care professionals and biomedical scientists, research in the health sciences and provision of comprehensive health care.

Stemgent Inc

Stemgent Inc is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

York Hospital

York Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in York, ME. To find more information about York Hospital, please visit www.yorkhospital.com

Furiex

Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.